Concentration-dependent clinical and prognostic importance of high-sensitivity cardiac troponin T in heart failure and a reduced ejection fraction and the influence of empagliflozin: the EMPEROR-Reduced trial.

When considered as a continuous variable, the treatment by log e hs‐cTnT interaction was nominally significant ( P = 0.043) with a greater effect of empagliflozin on the combined risk of cardiovascular death or hospitalization for heart failure in patients with lower levels of hs‐cTnT when displayed as a hazard ratio, but not when displayed as absolute risk reduction ( Figure 2 ).

also in 7,732 other papers